COMPOSITION PHARMACEUTIQUE COMPRENANT DE L'AZATHIOPRINE EN TANT QUE PRINCIPE ACTIF POUR LA PRÉVENTION OU LE TRAITEMENT DE TUMEURS DU CERVEAU OU DE GLIOBLASTOMES RÉSISTANTS À TÉMODAL
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY;SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
发明人:
CHO, HEEYEONG,CHOI, GILDON,PARK, WOO KYU,JEONG, DAE YOUNG,KIM, HYEON YOUNG,LEE, SUNKYUNG,NAM, DO HYUN,SEOL, HO JUN
申请号：
EP13816643
公开号：
EP2873419A4
申请日:
2013.07.10
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical composition for the prevention or treatment of cancer or Temodal resistant glioblastoma multiform comprising azathioprine as an active ingredient. The azathioprine of the present invention is not only effective in inhibiting the growth of glioblastoma multiform, a kind of brain tumor, but also excellent in treating glioblastoma multiform that displays resistance against Temodal (temozolomide), the conventional therapeutic agent for glioblastoma multiform, so that it can be effectively used as an active ingredient of a pharmaceutical composition for the prevention or treatment of such cancer as brain tumor (particularly, glioblastoma multiform) and particularly Temodal resistant glioblastoma multiform.
